No matter what size MedTech company you are, IP is critical to your company. It is the lifeblood that translates good ideas into new profitable endeavors. It’s what drives its value and also what makes you an attractive target for strategic partnerships with a larger company. One recent example is […]
Getting paid is one of the essential terms in a licensing agreement. Negotiating the right royalty rate makes the difference between generating income and creating a fortune. One of my clients discovered this the hard way. After they signed their licensing deal, they realized the royalty rate was too low. […]
Sometimes an IP is more valuable inside someone else’s product than as your own standalone product. Instead of spending all your money on manufacturing, distribution and sales, licensing your IP to companies who in turn integrate it into their products and pay you a licensing fee for every product sold is a smart business strategy.
With licensing, there’s no need to struggle to grow your startup or business internally, trying to raise capital by selling more equity and taking on the costly overhead. Instead, you reach out to partners who in turn license your IP for different products and markets, enabling your company to grow with no limitations and unlimited income opportunities.
If you’re like most MedTech companies, you’re focused on running your business. The problem is the healthcare market is a moving target, and that means what exists today, will be different tomorrow. Changing regulations, shifting customers, increasing competition, and an onslaught of new technologies entering the healthcare marketplace are just […]